Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

AIMS: Non-vitamin K oral anticoagulants are safe and effective for stroke prevention in patients with atrial fibrillation (AF). Data on the safety and efficacy of edoxaban in routine care are limited in Europe. We report 1-year outcomes in patients with AF treated with edoxaban in routine care. METH...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Heart J Cardiovasc Pharmacother
Hlavní autoři: de Groot, Joris R, Weiss, Thomas W, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Waltenberger, Johannes, Steffel, Jan, Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Manu, Marius Constantin, Reimitz, Paul-Egbert, De Caterina, Raffaele, Kirchhof, Paulus
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117428/
https://ncbi.nlm.nih.gov/pubmed/32790837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcvp/pvaa079
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky